CellaVision AB (C26) Stock Statistics & Valuation Metrics

CellaVision AB has a market cap or net worth of €317.99M. The enterprise value is €3.13K.

CellaVision AB has 23,851,547 shares outstanding. The number of shares has decreased by -2.65% in one year.

CellaVision AB’s return on equity (ROE) is 0.17 and return on invested capital (ROIC) is 15.96%.

The current PE Ratio of CellaVision AB is 26.2. CellaVision AB’s PEG ratio is 2.78.

In the last 12 months, CellaVision AB had revenue of 758.97M and earned 153.08M in profits. Earnings per share was 6.42.

In the last 12 months, operating cash flow was 172.59M and capital expenditures -60.26M, giving a free cash flow of 112.33M billion.

CellaVision AB pays an annual dividend of ―, resulting in a dividend yield of ―

CellaVision AB upcoming earnings date is Oct 29, 2026, Before Open (Confirmed).

CellaVision AB as a current ratio of 3.98, with Debt / Equity ratio of 2.45%

In the past 12 months, CellaVision AB has paid 41.19M in taxes.

CellaVision AB EV to EBITDA ratio is 15.12, with an EV/FCF ratio of 19.74.

CellaVision AB has €172.19M in cash and marketable securities with €52.27M in debt, giving a net cash position of €119.92M billion.

Gross margin is 67.98%, with operating margin of 26.62%, and net profit margin of 20.17%.

The average price target for CellaVision AB is €13.58, which is 11.43% higher than the current price. The consensus rating is Hold